Schulman ES - Search Results

1

Adenosine 5'-triphosphate's role in bradycardia and syncope associated with pulmonary embolism.

Pelleg A, Schulman ES, Barnes PJ. Pelleg A, et al. Among authors: schulman es. Respir Res. 2018 Jul 28;19(1):142. doi: 10.1186/s12931-018-0848-2. Respir Res. 2018. PMID: 30055609 Free PMC article. Review.

2

Adenosine 5'-triphosphate axis in obstructive airway diseases.

Pelleg A, Schulman ES. Pelleg A, et al. Among authors: schulman es. Am J Ther. 2002 Sep-Oct;9(5):454-64. doi: 10.1097/00045391-200209000-00014. Am J Ther. 2002. PMID: 12237739 Review.

3

Extracellular Adenosine 5'-Triphosphate in Obstructive Airway Diseases.

Pelleg A, Schulman ES, Barnes PJ. Pelleg A, et al. Among authors: schulman es. Chest. 2016 Oct;150(4):908-915. doi: 10.1016/j.chest.2016.06.045. Epub 2016 Aug 25. Chest. 2016. PMID: 27568579 Review.

4

IgE Receptor-Mediated Histamine Release in Human Lung Mast Cells: Modulation by Purinergic Receptor Ligands.

Nishi H, Pelleg A, Schulman ES. Nishi H, et al. Among authors: schulman es. Ann Clin Lab Sci. 2016 Sep;46(5):463-9. Ann Clin Lab Sci. 2016. PMID: 27650611

5

ATP modulates anti-IgE-induced release of histamine from human lung mast cells.

Schulman ES, Glaum MC, Post T, Wang Y, Raible DG, Mohanty J, Butterfield JH, Pelleg A. Schulman ES, et al. Am J Respir Cell Mol Biol. 1999 Mar;20(3):530-7. doi: 10.1165/ajrcmb.20.3.3387. Am J Respir Cell Mol Biol. 1999. PMID: 10030852

6

Enhancement of Mast Cell Degranulation Mediated by Purinergic Receptors' Activation and PI3K Type δ.

Nishi H, Niyonsaba F, Pelleg A, Schulman ES. Nishi H, et al. Among authors: schulman es. J Immunol. 2021 Aug 15;207(4):1001-1008. doi: 10.4049/jimmunol.2001002. Epub 2021 Jul 30. J Immunol. 2021. PMID: 34330752

7

Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.

Mohanty JG, Raible DG, McDermott LJ, Pelleg A, Schulman ES. Mohanty JG, et al. Among authors: schulman es. J Allergy Clin Immunol. 2001 May;107(5):849-55. doi: 10.1067/mai.2001.114658. J Allergy Clin Immunol. 2001. PMID: 11344352

8

Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease.

Berger M, Geng B, Cameron DW, Murphy LM, Schulman ES. Berger M, et al. Among authors: schulman es. Respir Med. 2017 Nov;132:181-188. doi: 10.1016/j.rmed.2017.10.016. Epub 2017 Oct 21. Respir Med. 2017. PMID: 29229095 Free article. Review.

9

Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders.

Schulman ES. Schulman ES. Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 2):S6-11. doi: 10.1164/ajrccm.164.supplement_1.2103025. Am J Respir Crit Care Med. 2001. PMID: 11704611 Review.

10

Low density lipoprotein (LDL) inhibits histamine release from human mast cells.

Schulman ES, Quinn TJ, Post TJ, O'Donnell P, Rodriguez A, Gonen B. Schulman ES, et al. Biochem Biophys Res Commun. 1987 Oct 29;148(2):553-9. doi: 10.1016/0006-291x(87)90912-0. Biochem Biophys Res Commun. 1987. PMID: 2446600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters